Cargando…

Mitochondrial Bioenergy in Neurodegenerative Disease: Huntington and Parkinson

Strong evidence suggests a correlation between degeneration and mitochondrial deficiency. Typical cases of degeneration can be observed in physiological phenomena (i.e., ageing) as well as in neurological neurodegenerative diseases and cancer. All these pathologies have the dyshomeostasis of mitocho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tassone, Annalisa, Meringolo, Maria, Ponterio, Giulia, Bonsi, Paola, Schirinzi, Tommaso, Martella, Giuseppina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138549/ https://www.ncbi.nlm.nih.gov/pubmed/37108382 http://dx.doi.org/10.3390/ijms24087221

Ejemplares similares

Loss of Non-Apoptotic Role of Caspase-3 in the PINK1 Mouse Model of Parkinson’s Disease
por: Imbriani, Paola, et al.
Publicado: (2019)

Vesicular Acetylcholine Transporter Alters Cholinergic Tone and Synaptic Plasticity in DYT1 Dystonia
por: Tassone, Annalisa, et al.
Publicado: (2021)

Alpha‐Synuclein is Involved in DYT1 Dystonia Striatal Synaptic Dysfunction
por: Ponterio, Giulia, et al.
Publicado: (2022)

Centrality of Striatal Cholinergic Transmission in Basal Ganglia Function
por: Bonsi, Paola, et al.
Publicado: (2011)

Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission
por: Montanari, Martina, et al.
Publicado: (2022)

Centrality of Early Synaptopathy in Parkinson’s Disease
por: Imbriani, Paola, et al.
Publicado: (2018)

Double hit mouse model of Parkinson's disease
por: Schirinzi, Tommaso, et al.
Publicado: (2016)

Developmental Profile of the Aberrant Dopamine D2 Receptor Response in Striatal Cholinergic Interneurons in DYT1 Dystonia
por: Sciamanna, Giuseppe, et al.
Publicado: (2011)

Early structural and functional plasticity alterations in a susceptibility period of DYT1 dystonia mouse striatum
por: Maltese, Marta, et al.
Publicado: (2018)

RGS9‐2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models
por: Bonsi, Paola, et al.
Publicado: (2018)

Beyond the Microbiota: Understanding the Role of the Enteric Nervous System in Parkinson’s Disease from Mice to Human
por: Montanari, Martina, et al.
Publicado: (2023)

Pattern of Mitochondrial Respiration in Peripheral Blood Cells of Patients with Parkinson’s Disease
por: Schirinzi, Tommaso, et al.
Publicado: (2022)

Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease
por: Franco-Iborra, Sandra, et al.
Publicado: (2018)

Torsin A Localization in the Mouse Cerebellar Synaptic Circuitry
por: Puglisi, Francesca, et al.
Publicado: (2013)

Outlining a Population “at Risk” of Parkinson's Disease: Evidence from a Case-Control Study
por: Schirinzi, Tommaso, et al.
Publicado: (2016)

Neurodegenerative processes in Huntington's disease
por: Bano, D, et al.
Publicado: (2011)

Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence
por: Schirinzi, Tommaso, et al.
Publicado: (2019)

Optogenetic stimulation reveals distinct modulatory properties of thalamostriatal vs corticostriatal glutamatergic inputs to fast-spiking interneurons
por: Sciamanna, Giuseppe, et al.
Publicado: (2015)

Synaptic Activity and Bioenergy Homeostasis: Implications in Brain Trauma and Neurodegenerative Diseases
por: Khatri, Natasha, et al.
Publicado: (2013)

Evidence for a Pan-Neurodegenerative Disease Response in Huntington's and Parkinson's Disease Expression Profiles
por: Labadorf, Adam, et al.
Publicado: (2018)

Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer’s, Parkinson’s, and Huntington’s Diseases and Amyotrophic Lateral Sclerosis
por: Ciurea, Alexandru Vlad, et al.
Publicado: (2023)

Synaptic Plasticity Changes: Hallmark for Neurological and Psychiatric Disorders
por: Martella, Giuseppina, et al.
Publicado: (2018)

Mitochondrial Neurodegenerative Diseases: Three Mitochondrial Ribosomal Proteins as Intermediate Stage in the Pathway That Associates Damaged Genes with Alzheimer’s and Parkinson’s
por: Del Giudice, Luigi, et al.
Publicado: (2023)

Prion‐like mechanisms in neurodegenerative disease: Implications for Huntington's disease therapy
por: Srinageshwar, Bhairavi, et al.
Publicado: (2020)

Potential Clinical Role of Prokineticin 2 (PK2) in Neurodegenerative Diseases
por: Maftei, Daniela, et al.
Publicado: (2022)

Translating cell therapies for neurodegenerative diseases: Huntington’s disease as a model disorder
por: Rosser, Anne E., et al.
Publicado: (2022)

Bioenergy and African transformation
por: Lynd, Lee R, et al.
Publicado: (2015)

Pisa Syndrome in Parkinson's Disease: Evidence for Bilateral Vestibulospinal Dysfunction
por: Di Lazzaro, Giulia, et al.
Publicado: (2018)

Bioenergy
por: Wall, Judy, et al.
Publicado: (2008)

Crosstalk between the Hippo Pathway and the Wnt Pathway in Huntington’s Disease and Other Neurodegenerative Disorders
por: Sileo, Pasquale, et al.
Publicado: (2022)

Neuro-Cardio Mechanisms in Huntington’s Disease and Other Neurodegenerative Disorders
por: Critchley, Bethan J., et al.
Publicado: (2018)

Alpha-Klotho in Parkinson’s disease: a perspective on experimental evidence and potential clinical implications
por: Grillo, Piergiorgio, et al.
Publicado: (2022)

Home-Based Exercise to Improve Motor Functions, Cognitive Functions, and Quality of Life in People with Huntington’s Disease: A Systematic Review and Meta-Analysis
por: Al-Wardat, Mohammad, et al.
Publicado: (2022)

Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases
por: Gao, Ju, et al.
Publicado: (2017)

Bioenergy Crisis in Coronavirus Diseases?
por: Dutta, Anirban, et al.
Publicado: (2020)

Advances in bioenergy
por: Li, Yebo, et al.
Publicado: (2016)

The future of bioenergy
por: Reid, Walter V., et al.
Publicado: (2019)

Management of Huntington’s disease: role of tetrabenazine
por: de Tommaso, Marina, et al.
Publicado: (2011)

Mitochondria in Huntington’s disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies
por: Jurcau, Anamaria, et al.
Publicado: (2022)

Redefining Agricultural Residues as Bioenergy Feedstocks
por: Caicedo, Marlon, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mk83h5a90agv1ieqomg62duugf